Abstract: There is disclosed an oral pharmaceutical composition for the treatment of multiple diseases comprising a denatonium cation salt and a sour anion selected from the group consisting of acetate (DA), citrate (DC) tartrate (CT), maleate (DM) and combinations thereof (collectively “denatonium salt”) and pharmaceutical excipients for gastric release of the denatonium salt. There is further disclosed an oral immediate release pharmaceutical composition to substantially release an API (active pharmaceutical ingredient) in the gastric area of the GI tract formulation, wherein the API comprises an effective amount of the denatonium salt. Preferably, the oral immediate release pharmaceutical formulation comprises from about 0.5 g to about 5 g of the denatonium salt delivering a daily dose of the denatonium salt from about 20 mg to about 150 mg to a human adult.

Abstract: Irrigation and/or aspiration devices and methods may be configured to aspirate and irrigate alone, sequentially, or concurrently. The devices and methods may provide a base with a removable head, and adapted for partial or complete separation of the irrigation and aspiration functions. The devices and methods can be configured to aspirate and/or irrigate the nasal and sinus cavities. The devices and methods may be manually and/or automatically controlled. The devices and methods may include removable, and/or replaceable, and/or refillable, and easily cleanable reservoirs for aspirant and irrigant. The device head and/or aspirant reservoir may comprise a diagnostic device, i.e., test device and/or container after use of the devices and methods.

Abstract: Irrigation and/or aspiration devices and methods may be configured to aspirate and irrigate alone, sequentially, or concurrently. The devices and methods may provide a base with a removable head, and adapted for partial or complete separation of the irrigation and aspiration functions. The devices and methods can be configured to aspirate and/or irrigate the nasal and sinus cavities. The devices and methods may be manually and/or automatically controlled. The devices and methods may include removable, and/or replaceable, and/or refillable, and easily cleanable reservoirs for aspirant and irrigant. The device head and/or aspirant reservoir may comprise a diagnostic device, i.e., test device and/or container after use of the devices and methods.

Abstract: Irrigation and/or aspiration devices and methods may be configured to aspirate and irrigate alone, sequentially, or concurrently. The devices and methods may provide a base with a removable head, and adapted for partial or complete separation of the irrigation and aspiration functions. The devices and methods can be configured to aspirate and/or irrigate the nasal and sinus cavities. The devices and methods may be manually and/or automatically controlled. The devices and methods may include removable, and/or replaceable, and/or refillable, and easily cleanable reservoirs for aspirant and irrigant. The device head and/or aspirant reservoir may comprise a diagnostic device, i.e., test device and/or container after use of the devices and methods.

Abstract: There is disclosed an oral pharmaceutical composition for the treatment of multiple diseases comprising a denatonium cation salt and a sour anion selected from the group consisting of acetate (DA), citrate (DC) tartrate (CT), maleate (DM) and combinations thereof (collectively “denatonium salt”) and pharmaceutical excipients for gastric release of the denatonium salt. There is further disclosed an oral immediate release pharmaceutical composition to substantially release an API (active pharmaceutical ingredient) in the gastric area of the GI tract formulation, wherein the API comprises an effective amount of the denatonium salt. Preferably, the oral immediate release pharmaceutical formulation comprises from about 0.5 g to about 5 g of the denatonium salt delivering a daily dose of the denatonium salt from about 20 mg to about 150 mg to a human adult.

Abstract: A tactical cummerbund for use with a tactical vest having a right, front vest connector and a left, front vest connector. The cummerbund includes an elastic connecting band and a protective right side portion and protective left side portion which connect to opposite ends of the connecting band. The connecting band may be positioned in the center of a channel in the back panel of the tactical vest such that it is protected from the elements. The connections of the right side portion and left side portion to the connecting band are adjustable to adjust the girth of the cummerbund.

Abstract: A vehicle has a first showroom enclosure at a first side of the vehicle body and a second showroom at an opposite side of the vehicle body. A storage area is provided between the first and second showroom and can be accessed by a door at the rear of the vehicle body, or at access panels located at the first and/or second sides of the vehicle body.

Abstract: Irrigation and/or aspiration devices and methods may be configured to aspirate and irrigate alone, sequentially, or concurrently. The devices and methods may provide a base with a removable head, and adapted for partial or complete separation of the irrigation and aspiration functions. The devices and methods can be configured to aspirate and/or irrigate the nasal and sinus cavities. The devices and methods may be manually and/or automatically controlled. The devices and methods may include removable, and/or replaceable, and/or refillable, and easily cleanable reservoirs for aspirant and irrigant. The device head and/or aspirant reservoir may comprise a diagnostic device, i.e., test device and/or container after use of the devices and methods.

Abstract: A tactical shoulder garment with a ballistic carrier and a removably attachable shoulder strap.

Abstract: There is disclosed an oral pharmaceutical formulation of bitter compounds that are agonists of taste receptor type 2 (TAS2R) receptors for the function of appetite suppression for the treatment of obesity. More specifically, the present disclosure provides an anti-obesity oral formulation comprising a bitter agent selected from the group consisting of denatonium salts including benzoate (DB), chloride (DC), acetate (DA), citrate (DCl), saccharide (DS), tartarate (DT), maleate (DM), 3-caffeoylquinic-1,5-lactone (3-CQL), chlorogenic acids (CGA), combinations thereof, and pharmaceutical excipients to facilitate a sustained release during transit through the gastrointestinal (GI) tract. Preferably, the oral pharmaceutical formulation further comprises either or both a sweet antagonist selected from the group consisting of lactisole, gymnemic acid, ziziphin, hodulcine, and combinations thereof, and a sour organic acid.

Abstract: A tactical shoulder garment with a ballistic carrier and a removably attachable shoulder strap,

Abstract: A tactical cummerbund for use with a tactical vest having a right, front vest connector and a left, front vest connector. The cummerbund includes an elastic connecting band and a protective right side portion and protective left side portion which connect to opposite ends of the connecting band. The connecting band may be positioned in the center of a channel in the back panel of the tactical vest such that it is protected from the elements. The connections of the right side portion and left side portion to the connecting band are adjustable to adjust the girth of the cummerbund.

Abstract: A loadout exchange system includes a back panel and a front panel. The back panel has a front side with a hook and loop surface, a back side with a MOLLE-compatible surface, one or more tab locks, and one or more straps. The front panel has a front side with a MOLLE-compatible surface, a back side with a hook and loop surface, one or more pull tabs, and one or more tuck tabs with a hook and loop surface. The front surface of the back panel and the back surface of the front panel are complimentary and thus configured to mate with each other to be removably secured to each other. The tab locks and pull tabs also have complimentary hook and loop surfaces and are thus configured to mate with each other to be removably secured to each other.

Abstract: There is disclosed an oral pharmaceutical formulation of bitter compounds that are agonists of taste receptor type 2 (TAS2R) receptors for the function of appetite suppression for the treatment of obesity. More specifically, the present disclosure provides an anti-obesity oral formulation comprising a bitter agent selected from the group consisting of denatonium salts including benzoate (DB), chloride (DC), acetate (DA), citrate (DCl), saccharide (DS), tartarate (DT), maleate (DM), 3-caffeoylquinic-1,5-lactone (3-CQL), chlorogenic acids (CGA), combinations thereof, and pharmaceutical excipients to facilitate a sustained release during transit through the gastrointestinal (GI) tract. Preferably, the oral pharmaceutical formulation further comprises either or both a sweet antagonist selected from the group consisting of lactisole, gymnemic acid, ziziphin, hodulcine, and combinations thereof, and a sour organic acid.

Abstract: Irrigation and/or aspiration devices and methods may be configured to aspirate and irrigate alone, sequentially, or concurrently. The devices and methods may provide a base with a removable head, and adapted for partial or complete separation of the irrigation and aspiration functions. The devices and methods can be configured to aspirate and/or irrigate the nasal and sinus cavities. The devices and methods may be manually and/or automatically controlled. The devices and methods may include removable, and/or replaceable, and/or refillable, and easily cleanable reservoirs for aspirant and irrigant. The device head and/or aspirant reservoir may comprise a diagnostic device, i.e., test device and/or container after use of the devices and methods.

Abstract: An irrigation and aspiration system is disclosed. The system can be configured to aspirate and irrigate alone, sequentially or concurrently. The system can be configured to aspirate and irrigate the nasal cavity. The system can be manually controlled. The system can have removable and easily cleanable reservoirs for aspirant and irrigant.

Abstract: A loadout exchange system includes a back panel and a front panel. The back panel has a front side with a hook and loop surface, a back side with a MOLLE-compatible surface, one or more tab locks, and one or more straps. The front panel has a front side with a MOLLE-compatible surface, a back side with a hook and loop surface, one or more pull tabs, and one or more tuck tabs with a hook and loop surface. The front surface of the back panel and the back surface of the front panel are complimentary and thus configured to mate with each other to be removably secured to each other. The tab locks and pull tabs also have complimentary hook and loop surfaces and are thus configured to mate with each other to be removably secured to each other.

Abstract: A loadout exchange system includes a back panel and a front panel. The back panel has a front side with a hook and loop surface, a back side with a MOLLE-compatible surface, one or more tab locks, and one or more straps. The front panel has a front side with a MOLLE-compatible surface, a back side with a hook and loop surface, one or more pull tabs, and one or more tuck tabs with a hook and loop surface. The front surface of the back panel and the back surface of the front panel are complimentary and thus configured to mate with each other to be removably secured to each other. The tab locks and pull tabs also have complimentary hook and loop surfaces and are thus configured to mate with each other to be removably secured to each other.